TrialNature communications2024

Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial.

Henriette U Balinda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.